Paper40536628
Clinical and Genetic Profile of 35 Patients with Glycogen Storage Disease Type 1b: A Comparative Analysis Before and During SGLT2 Inhibitor Therapy.
Milosevic MD and 6 others. Mol Diagn Ther, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Clinical and Genetic Profile of 35 Patients with Glycogen Storage Disease Type 1b: A Comparative Analysis Before and During SGLT2 Inhibitor Therapy. Papers, record 40536628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40536628
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical and Genetic Profile of 35 Patients with Glycogen Storage Disease Type 1b: A Comparative Analysis Before and During SGLT2 Inhibitor Therapy.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glycogen Storage Disease Type I | Major topic |
| Sodium-Glucose Transporter 2 Inhibitors | Major topic |
| Benzhydryl Compounds | Major topic |
| Humans | |
| Female | |
| Male | |
| Child | |
| Adolescent | |
| Child, Preschool | |
| Genotype | |
| Monosaccharide Transport Proteins | |
| Adult | |
| Quality of Life | |
| Young Adult | |
| Mutation | |
| High-Throughput Nucleotide Sequencing | |
| Glucosides | |
| Antiporters |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 6999 | Science Fund of Republic of Serbia | PubMed |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17994282 | Elevated serum biotinidase activity in hepatic glycogen storage disorders--a convenient biomarker. | J Inherit Metab Dis | 2007 | https://conductscience.org/library/papers/17994282 | PubMed |
| 2 | 38185897 | Repurposing empagliflozin in individuals with glycogen storage disease Ib: A value-based healthcare approach and systematic benefit-risk assessment. | J Inherit Metab Dis | 2024 | https://conductscience.org/library/papers/38185897 | PubMed |
| 3 | 35620924 | Clinical characteristics and long-term outcomes of patients with glycogen storage disease type 1b: a retrospective multi-center experience in Poland. | Pediatr Endocrinol Diabetes Metab | 2022 | https://conductscience.org/library/papers/35620924 | PubMed |
| 4 | 12373579 | Association of glycogen storage disease 1b and Crohn disease: results of a North American survey. | Eur J Pediatr | 2002 | https://conductscience.org/library/papers/12373579 | PubMed |
| 5 | 32838757 | Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib. | Orphanet J Rare Dis | 2020 | https://conductscience.org/library/papers/32838757 | PubMed |
| 6 | 32461654 | The mutational constraint spectrum quantified from variation in 141,456 humans. | Nature | 2020 | https://conductscience.org/library/papers/32461654 | PubMed |
| 7 | 15050885 | Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. | Am J Med | 2004 | https://conductscience.org/library/papers/15050885 | PubMed |
| 8 | 36143432 | Crosstalk between Glycogen-Selective Autophagy, Autophagy and Apoptosis as a Road towards Modifier Gene Discovery and New Therapeutic Strategies for Glycogen Storage Diseases. | Life (Basel) | 2022 | https://conductscience.org/library/papers/36143432 | PubMed |
| 9 | 25288127 | Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes. | J Inherit Metab Dis | 2015 | https://conductscience.org/library/papers/25288127 | PubMed |
| 10 | 28224773 | Novel SLC37A4 Mutations in Korean Patients With Glycogen Storage Disease Ib. | Ann Lab Med | 2017 | https://conductscience.org/library/papers/28224773 | PubMed |
| 11 | 33977030 | The natural history of glycogen storage disease type Ib in England: A multisite survey. | JIMD Rep | 2021 | https://conductscience.org/library/papers/33977030 | PubMed |
| 12 | 38605407 | Clinical spectrum, over 12-year follow-up and experience of SGLT2 inhibitors treatment on patients with glycogen storage disease type Ib: a single-center retrospective study. | Orphanet J Rare Dis | 2024 | https://conductscience.org/library/papers/38605407 | PubMed |
| 13 | 30956637 | Molecular diagnosis of glycogen storage disease type I: a review. | EXCLI J | 2019 | https://conductscience.org/library/papers/30956637 | PubMed |
| 14 | 35503103 | Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire. | Genet Med | 2022 | https://conductscience.org/library/papers/35503103 | PubMed |
| 15 | 10931410 | Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. | J Pediatr | 2000 | https://conductscience.org/library/papers/10931410 | PubMed |
| 16 | 28685844 | Genetic characterization of GSD I in Serbian population revealed unexpectedly high incidence of GSD Ib and 3 novel SLC37A4 variants. | Clin Genet | 2018 | https://conductscience.org/library/papers/28685844 | PubMed |
| 17 | 25356975 | Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. | Genet Med | 2014 | https://conductscience.org/library/papers/25356975 | PubMed |
| 18 | 28389590 | Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function. | J Immunol | 2017 | https://conductscience.org/library/papers/28389590 | PubMed |
| 19 | 25741868 | Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. | Genet Med | 2015 | https://conductscience.org/library/papers/25741868 | PubMed |
| 20 | 29719821 | The Physiopathological Role of the Exchangers Belonging to the SLC37 Family. | Front Chem | 2018 | https://conductscience.org/library/papers/29719821 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42975668 | Targeting proximal tubulopathy in Fanconi-Bickel syndrome: A case series of empagliflozin treatment. | Pediatr Nephrol | 2026 | https://conductscience.org/library/papers/42975668 | PubMed |
| 42597621 | Empagliflozin in GSD-Ib: Long-term safety and sustained recovery of neutrophil function including NET formation. | Mol Genet Metab Rep | 2026 | https://conductscience.org/library/papers/42597621 | PubMed |
| 42070995 | Shifting Towards Empagliflozin First-Line Therapy in Glycogen Storage Disease Type Ib: A Nationwide Real-World Study. | J Inherit Metab Dis | 2026 | https://conductscience.org/library/papers/42070995 | PubMed |
| 41891992 | First Reported Use of Recombinant Parathyroid Hormone in Kenny-Caffey Syndrome Type 2: A Case Report and Literature Review. | Diseases | 2026 | https://conductscience.org/library/papers/41891992 | PubMed |
| 41603948 | Safety of SGLT-2 inhibitors in patients with glycogen storage disease type Ib and their efficacy in treating disease-associated digestive symptoms and disorders. | Acta Diabetol | 2026 | https://conductscience.org/library/papers/41603948 | PubMed |
| 41118060 | Comparative risks of inflammatory bowel disease in patients with type 2 diabetes mellitus treated with SGLT-2 inhibitors versus DPP-4 inhibitors: a real-world nationwide cohort study. | Int J Clin Pharm | 2025 | https://conductscience.org/library/papers/41118060 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SLC37A4 | 2542 | PubTator's text mining | https://conductscience.org/library/genes/2542 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40536628
GET https://conductscience.org/api/papers/v1/40536628/references?page=2